This is calculated as R&D expenditures divided by total assets. R&D expense is not always broken out in a company's financials, however, so this value may be n/a in those cases.
Like R&D / Sales, this is a measure of R&D intensity. It is useful in comparing the effectiveness of R&D expenditures between companies in the same industry. It is less obvious across industries - for example, pharmaceuticals and software companies tend to spend a lot on R&D while consumer product companies spent less.
| Ticker | Name | R&D to Assets | StockRank™ |
|---|---|---|---|
| OTC:ALRT | ALR Technologies Inc | 57187.18 | 40 |
| OTC:ETNI | Entest Inc | 19230.77 | 40 |
| OTC:PLYZ | Plyzer Technologies Inc | 10959.48 | 36 |
| OTC:BZYR | Burzynski Research Institute Inc | 9315.24 | 4 |
| OTC:FDBL | Friendable Inc | 6208.94 | 2 |
Let’s get you setup so you get the most out of our service
Brilliant - You've created a folio! Now let's add some stocks to it.
